Börsenlotse
Kauftag heute: Gut (60 ) Gemischte Marktbreite · Breite steigend (+5 zum 10-Tage-Schnitt) · kein Makro-Großtermin

Insider-Trading

Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.

Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).
Ticker Insider Funktion Datum Transaktion Kurs ($) Stück Wert ($) SEC Form 4
SYRE Burrows Scott L Chief Financial Officer 03.08.2026 Verkauf 97,10 100 9.710 Form 4
SYRE Burrows Scott L Chief Financial Officer 03.08.2026 Verkauf 96,30 2.300 221.490 Form 4
SYRE Burrows Scott L Chief Financial Officer 03.08.2026 Verkauf 95,21 5.100 485.571 Form 4
SYRE Burrows Scott L Chief Financial Officer 03.08.2026 Optionsausübung 14,50 7.500 108.750 Form 4
SYRE Turtle Cameron Chief Executive Officer 03.08.2026 Verkauf 97,46 16 1.559 Form 4
SYRE Turtle Cameron Chief Executive Officer 03.08.2026 Verkauf 96,82 1.392 134.773 Form 4
SYRE Turtle Cameron Chief Executive Officer 03.08.2026 Verkauf 95,93 5.635 540.566 Form 4
SYRE Turtle Cameron Chief Executive Officer 03.08.2026 Verkauf 95,10 7.157 680.631 Form 4
SYRE Turtle Cameron Chief Executive Officer 03.08.2026 Verkauf 93,97 800 75.176 Form 4
SFM Sinclair Jack Chief Executive Officer 03.08.2026 Verkauf 89,34 10.788 963.757 Form 4
SFM Sinclair Jack Chief Executive Officer 03.08.2026 Optionsausübung 16,47 10.788 177.678 Form 4
SPT Rankin Aaron Edward Frederick Chief Technology Officer 03.08.2026 Zuteilung 120.192 Form 4
SPOT Norstrom Alex Co-Chief Executive Officer 03.08.2026 Verkauf 506,04 315 159.404 Form 4
SPOT Norstrom Alex Co-Chief Executive Officer 03.08.2026 Verkauf 503,86 254 127.979 Form 4
SPOT Norstrom Alex Co-Chief Executive Officer 03.08.2026 Verkauf 502,86 1.159 582.812 Form 4
SPOT Norstrom Alex Co-Chief Executive Officer 03.08.2026 Verkauf 502,05 1.865 936.314 Form 4
SPOT Norstrom Alex Co-Chief Executive Officer 03.08.2026 Verkauf 501,16 1.253 627.951 Form 4
SPOT Norstrom Alex Co-Chief Executive Officer 03.08.2026 Verkauf 499,96 590 294.975 Form 4
SPOT Norstrom Alex Co-Chief Executive Officer 03.08.2026 Optionsausübung 151,25 5.436 822.195 Form 4
SPOT Soderstrom Gustav Co-Chief Executive Officer 03.08.2026 Verkauf 511,64 706 361.218 Form 4
SPOT Soderstrom Gustav Co-Chief Executive Officer 03.08.2026 Verkauf 510,94 4.089 2.089.223 Form 4
SPOT Soderstrom Gustav Co-Chief Executive Officer 03.08.2026 Verkauf 510,00 2.235 1.139.844 Form 4
SPOT Soderstrom Gustav Co-Chief Executive Officer 03.08.2026 Verkauf 508,99 2.377 1.209.878 Form 4
SPOT Soderstrom Gustav Co-Chief Executive Officer 03.08.2026 Verkauf 508,19 2.224 1.130.210 Form 4
SPOT Soderstrom Gustav Co-Chief Executive Officer 03.08.2026 Verkauf 506,87 2.054 1.041.112 Form 4
SPOT Soderstrom Gustav Co-Chief Executive Officer 03.08.2026 Verkauf 506,04 1.553 785.878 Form 4
SPOT Soderstrom Gustav Co-Chief Executive Officer 03.08.2026 Verkauf 504,76 242 122.152 Form 4
SPOT Soderstrom Gustav Co-Chief Executive Officer 03.08.2026 Verkauf 504,03 600 302.419 Form 4
SPOT Soderstrom Gustav Co-Chief Executive Officer 03.08.2026 Verkauf 502,90 1.574 791.570 Form 4
SPOT Soderstrom Gustav Co-Chief Executive Officer 03.08.2026 Verkauf 502,07 1.666 836.444 Form 4
SPOT Soderstrom Gustav Co-Chief Executive Officer 03.08.2026 Verkauf 501,17 744 372.869 Form 4
SPOT Soderstrom Gustav Co-Chief Executive Officer 03.08.2026 Verkauf 500,03 769 384.520 Form 4
SPOT Soderstrom Gustav Co-Chief Executive Officer 03.08.2026 Optionsausübung 151,25 20.833 3.150.991 Form 4
SPIR Mellinger Eric M. Chief Commercial Officer 03.08.2026 Zuteilung 150.000 Form 4
SNOW Kleinerman Christian EVP, Product Management 03.08.2026 Verkauf 300,00 5.000 1.500.000 Form 4
SLDE Gries Robert JR Director 03.08.2026 Verkauf 20,33 28.212 573.550 Form 4
SEPN Long Daniel D. SVP, Drug Discovery 03.08.2026 Verkauf 34,68 2.334 80.944 Form 4
SEPN Long Daniel D. SVP, Drug Discovery 03.08.2026 Verkauf 33,98 1.000 33.976 Form 4
SEPN Long Daniel D. SVP, Drug Discovery 03.08.2026 Optionsausübung 2,76 1.518 4.190 Form 4
SEPN Long Daniel D. SVP, Drug Discovery 03.08.2026 Optionsausübung 2,76 1.816 5.012 Form 4
SNDR Rourke Mark B. Executive Chair 03.08.2026 Verkauf 35,18 20.312 714.503 Form 4
SNDR Rourke Mark B. Executive Chair 03.08.2026 Optionsausübung 24,81 20.312 503.941 Form 4
IOT Phillips Dominic SEE REMARKS 03.08.2026 Verkauf 38,37 905 34.722 Form 4
IOT Phillips Dominic SEE REMARKS 03.08.2026 Verkauf 37,58 17.003 638.949 Form 4
IOT Phillips Dominic SEE REMARKS 03.08.2026 Verkauf 38,40 600 23.038 Form 4
IOT Phillips Dominic SEE REMARKS 03.08.2026 Verkauf 37,58 11.110 417.550 Form 4
SPFI Campbell Richard D Director 03.08.2026 Verkauf 44,75 132.714 5.938.952 Form 4
SKYW Steel Wade J CHIEF COMMERCIAL OFFICER 03.08.2026 Verkauf 111,44 22.000 2.451.676 Form 4
SIBN Dunn Jeffrey W Director 03.08.2026 Verkauf 18,46 20.000 369.214 Form 4
SIBN Dunn Jeffrey W Director 03.08.2026 Optionsausübung 4,68 20.000 93.600 Form 4
SI Gilde Healthcare Holding B.V. 10% Owner 03.08.2026 Verkauf 22,71 10.751 244.155 Form 4
SHBI Lamon John Director 03.08.2026 Kauf 24,57 300 7.371 Form 4
LAES Enguent Jean-Pierre Vice President, R&DSS 03.08.2026 Optionsausübung 0,01 15.000 150 Form 4
SMG Hagedorn Partnership, L.P. Director 03.08.2026 Verkauf 68,16 1.207 82.271 Form 4
SMG Hagedorn Partnership, L.P. Director 03.08.2026 Verkauf 67,42 28.793 1.941.322 Form 4
RSI Stetz Mattias Chief Operating Officer 03.08.2026 Verkauf 28,03 20.000 560.556 Form 4
RSI Schwartz Richard Todd Chief Executive Officer 03.08.2026 Verkauf 28,02 55.556 1.556.890 Form 4
RSI Schwartz Richard Todd Chief Executive Officer 03.08.2026 Verkauf 28,02 47.222 1.323.250 Form 4
RSI Schwartz Richard Todd Chief Executive Officer 03.08.2026 Abgabe 55.556 Form 4
RSI Schwartz Richard Todd Chief Executive Officer 03.08.2026 Wandlung 55.556 Form 4

Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).

War diese Seite hilfreich für Dich?